chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 16 year old female who in August 2008, was vaccinated with the first dose of GARDASIL.  On 13-OCT-2008 was vaccinated with the second dose of GARDASIL.  The patient got a swollen eye (eye unspecified) after receiving GARDASIL.  On 15-OCT-2008 the patient was seen in the office today for a swollen eye diagnosed as periorbital edema.  In August 2008 the patient had a similar reaction following the first dose of GARDASIL, but the reaction after the first dose was described as "worse".  The physician treated the patient with eye drops (unspecified) and BENADRYL.  No time frame development information was available other than the mother brought the patient in "right away".  The patient's present status was not recovered.  Additional information has been requested.
Fever as high as 105 with seizures, gave ibuprofen and took to hospital.
Patient received J&J vaccine in the past (6/18/21), and came into pharmacy for 1st shot of pfizer. Pt stated he has not received any other vaccine in the past, and was given a pfizer vaccine today 7/23/21.
I was sick for two weeks with chills,fever and headaches.  went to er first and had covid (Negative) and blood work.  white blood cell count slightly elevated.  then on 2-25 still sick so I went to the doctor.
Initially on the first couple of days (Tues & Wed) I was experiencing the usual symptoms that were being reported. Localized Soreness at vaccination site, extreme fatigue, fever, and chills. Then on Thursday morning, I had chest pain that i've never experienced in my life. I went to a clinic where they ran an EKG report. There were off-signs that concluded I need to be sent to the hospital. An ambulance came and took me to hospital. I was met with a team of close to 12 doctors as they all checked for signs of heart attack. I stayed a total of 2 nights and 3 days in which several tests were conducted. EKG, Echogram, Angiogram, and an MRI. I was diagnosed with Myocarditis and Pericarditis. I have no history of smoking and I do not drink alcohol.
Patient fell, went to ER for evaluation, was given tetanus booster in ER, next day developed redness, pain, swelling in right arm at site of injection.  NO fever, area of redness, induration about 10 cm diameter.
Non productive cough; This spontaneous case was reported by an other health care professional and describes the occurrence of COUGH (Non productive cough) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Non productive cough). At the time of the report, COUGH (Non productive cough) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments
she got the vaccine back in Mar2021, but has not gotten the booster, she contracted the covid virus this past Jan2022; she got the vaccine back in Mar2021, but has not gotten the booster, she contracted the covid virus this past Jan2022; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team for a Pfizer sponsored program.  A 42 year-old female patient received bnt162b2 (BNT162B2), administration date Mar2021 (Batch/Lot number: unknown) as dose 2, single and administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "unknown" and all described as "she got the vaccine back in Mar2021, but has not gotten the booster, she contracted the covid virus this past Jan2022". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Jan2022) contracted; (Feb2022) negative twice, notes: asymptomatic. Therapeutic measures were not taken as a result of vaccination failure, covid-19.  Additional information: received the call from (Name withheld) with DSU NTID:# rep# (Withheld) (call was transferred from (Name withheld) with Covax support) Caller is a retired physician working for a dance company. He is asking on behalf of a 42-year-old female who received the doses of Pfizer BioNtech Covid vaccine on Mar2021. However she has contracted the Covid infection on Jan2022. She was not treated with any antibody or steroids during her infection. currently she has tested negative twice and is asymptomatic. Caller would like to know when would be the best time to receive the booster dose of Pfizer BioNtech vaccine, should they wait 90 days given that she had the infection on Jan2021.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of serious events drug ineffective and COVID-19 cannot be totally excluded.
puffy rash across the bridge of my nose and arching up to my right eyebrow; it is itchy; puffy rash; This case was reported by a consumer via call center representative and described the occurrence of rash in a 50-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th August 2020, the patient received the 1st dose of Shingrix. On 18th August 2020, 5 days after receiving Shingrix, the patient experienced rash, itchy rash and puffy skin. On an unknown date, the outcome of the rash, itchy rash and puffy skin were unknown.   It was unknown if the reporter considered the rash, itchy rash and puffy skin to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix about 5 days ago and at the date of reporting getting a puffy rash across the bridge of my nose and arching up to my right eyebrow and it was itchy.  The reporter asked was it possible for the vaccine to trigger a Shingles episode.
Patient was 13 months old and speaking single words. After the vaccines were given the patient stopped speaking any words and regressed without saying anything for months.
Symptoms include: fever, chills, ache, and headache.  Please note that headache lasted 2 additional days after shot
Patient is a new patient to our office when transferring shots over noted patient had received 2 HPV shots at doctor's office and 2 shots at another doctor.
Ringing in the ear-left side.; This is a spontaneous report from a contactable healthcare professional, the patient. A 56-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 03Apr2021 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not have any allergies to food, medications, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not have symptoms associated with COVID-19. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Apr2021 at 00:00, the patient experienced ringing in the ear-left side. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the adverse event. The clinical outcome of the event ringing in the ear-left side was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Within a few minutes after received the 2nd Dose of Moderna at 6:55pm, patient's face turned pale and broke out with cold sweat and his forehead cool to touch.  I checked his blood pressure at for the first time at the result are: 100/50 and pulse 45.  Patient told me beside breaking out cold sweat and dizziness, his breathing and everything else is fine.  After about 10 minutes later after resting, his cold sweat seem to stop and his face no longer pale.  I check his blood pressure again: 118/67, P=60.  Patient said he felt perfectly fine now without any symptoms.  However, I asked patient to stay for the full 30 minutes post vaccine where I just stood nearby and observe him closely until 7:25pm to be on the safe side.  At 7:25pm, patient said thank you for taking great care of him, and he felt fine and he left with his friend.  I called patient  today at 8:30pm for follow up, he picked up the phone and said he is feeling fine.
22OCT97 fainted 15min post vax & frightened about recv vax;hit the posterior aspect of head on floor;fell which results raised area approx 1cm high et 2cm in diameter;14NOV97 c/o visual disturbances (thing move fast), h/a;dx post vax synd
A week and a half ago he started bronchitis; A week and a half ago he started having cough; Chills once in a while; He had some itchy bumps on his body; A spontaneous report was received from consumer, who was also a male patient of unknown age, who received the Moderna COVID-19 (mRNA-1273) vaccine and developed a week and a half ago he started bronchitis/bronchitis, he had some itchy bumps on his body/rash pruritic, a week and a half ago he started having cough/cough, chills once in a while/chills.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.     The patient received first dose of two planned doses of mRNA-1273 (Batch number: unknown) on 17 Feb 2021 intramuscularly at unknown injection site for prophylaxis of COVID-19 infection.   The patient initially had some itchy bumps on his body and a week and a half ago he started having cough, bronchitis. Chills occasionally. The medically significant event is a week and a half ago he started bronchitis/bronchitis. Treatment for the event was not provided.  Action taken with mRNA-1273 in response to the event(s) was not provided.  The outcome of the events a week and a half ago he started bronchitis, he had some itchy bumps on his body, a week, and a half ago he started having cough, chills occasionally was not reported.; Reporter's Comments: This case concerns a male patient who developed a medically significant and serious unexpected event of bronchitis along with nonserious unexpected cough, pruritic rash and expected chills.  Event onset occurred on Day 5 after the first dose of mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
got the vaccine yesterday  and don't feel good; Chest Pain; Fever; body aches; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (got the vaccine yesterday  and don't feel good), CHEST PAIN (Chest Pain), PYREXIA (Fever) and MYALGIA (body aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (got the vaccine yesterday  and don't feel good), CHEST PAIN (Chest Pain), PYREXIA (Fever) and MYALGIA (body aches). At the time of the report, FEELING ABNORMAL (got the vaccine yesterday  and don't feel good), CHEST PAIN (Chest Pain), PYREXIA (Fever) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  No treatment medications provided by the reporter.
pt devel hives about 24-26 hr p/vax; pt had them ob both arms, behind knees, both hips & a few on neck, stomach & back;this lasted around 10-12hr;
arm felt like ti was on fire, red circle around injection site, still there after 3 weeks, extreme tiredness, racing heart off and on for 3 days. Felt like I had a fever but never did.
Influenza vaccine administered. Recipient reported 8 days later that immediately after receiving vaccine she felt tired and exhausted. By 8PM she vomited every 30 minutes. Fever of 103 degrees F by 7pm. Body pain, particularly in spine. Throat was tight for several days afterwards. Also short of breath days after.
Became unable to walk or maintain activities of daily living within 3 days of vaccination, followed by death within 10 days of vaccination.
Headache, Myalgia, Arthralgia, Diarrhea, Nausea, Vomiting, Chills, Fatigue Narrative:
on 5/6/2021 at 7:30AM my nose began bleeding from left nostal. Went to ED. Nose was cauterized. I was released & later in the day I was slightly feverish & tired.  On 5/9/2021 at approx 7:30 AM, left nostril began bleeding again. I was vomiting blood & blood was coming out of my tear ducts. I went to Hospital ED. They cauterized my nose using silver nitrate stick and inserted "rhino Rocket"5.5cc with 3cc of air. Was prescribed Keflex500mg pills 4x/day - 5 days 5/10/2021 Nose is oozing, feel slightly feaverish & achey
Shortness of breath, heart palpitations, headaches, muscles aches, fatigue, muscle fasciculations, joint pain, dizziness, anxiety.
About 2 hr after receiving vaccine pt called store & stated she had swelling, pain and hot at sight of injection.
low grade fatigue; body pains; fever; felt like she was hit by a truck; DIZZINESS; sweating; blood pressure was low (110/70); heart rate was low; trouble walking; VOMITING; Head was pounding; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt like she was hit by a truck), DIZZINESS (DIZZINESS), HYPERHIDROSIS (sweating), HYPOTENSION (blood pressure was low (110/70)) and HEART RATE DECREASED (heart rate was low) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced FEELING ABNORMAL (felt like she was hit by a truck), DIZZINESS (DIZZINESS), HYPERHIDROSIS (sweating), HYPOTENSION (blood pressure was low (110/70)), HEART RATE DECREASED (heart rate was low), GAIT DISTURBANCE (trouble walking), VOMITING (VOMITING), HEADACHE (Head was pounding), MYALGIA (body pains) and PYREXIA (fever). On 31-Mar-2021, the patient experienced FATIGUE (low grade fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 15-Mar-2021, FEELING ABNORMAL (felt like she was hit by a truck), DIZZINESS (DIZZINESS), HYPERHIDROSIS (sweating), HYPOTENSION (blood pressure was low (110/70)), HEART RATE DECREASED (heart rate was low), GAIT DISTURBANCE (trouble walking), VOMITING (VOMITING), HEADACHE (Head was pounding), MYALGIA (body pains) and PYREXIA (fever) had resolved. At the time of the report, FATIGUE (low grade fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: diagnosed APR/2020.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was reported
Information has been received from a health professional concerning a 5 year old male who on 26-FEB-2003 was vaccinated with a first subcutaneous dose in the right arm of Varivax (Lot # 643588/0804M). Concomitant vaccine administered on the same day included a first dose in the left deltoid of Havrix (Lot# VHA709A2). On 05-APR-2006 the patient was diagnosed with a rash with less than 150 lesions that began on 03-APR-2006. There was no fever, no reliable prior history of chickenpox, and no complications. Additional information has been requested.
Patient started to have headache that evening 30 minutes after vaccine was given.  Was up all night with muscle cramps in legs, arms and neck. Experienced large red area up to shoulder on vaccine arm.  Also experienced lower back and kidney aches with chills. Patient called MD and sent her back to pharmacy on 9/19 where her symptoms had improved. Recommended IBU or APAP for sore/swelled arm that was fading.
Vaccine with J&J on 06/4/21. COVID positive 1/10/22. PResented to ER on 1/10/22 and admitted. Patient initially tested positive for COVID-19 in urgent treatment clinic via rapid test. She tested negative 3 times with PCR inpatient. However, patient had CT chest findings consistent with COVID-19 PNA and thus was treated for it. Patient was desaturating on presentation to ED and was started on 3 L NC. She was started on decadron, doxycycline and rocephin. She did not qualify for remdesivir given negative PCR test for COVID-19. Patient continued to desaturate and required 6L on NC. Pulmonolgy was consulted and did see the patient. Patient was switched to azithromycin and continued rocephin and decadron. Additionally, she has uncontrolled T2DM and had elevated BG level during admission. Her insulin was increased to 70 units levemir BID with sliding scale dosing as well. Prior to discharge, decadron dose was decreased to 4 mg from 6 mg with some improvement of BG levels and decrease in basal insulin dose. She additionally had some PVCs see on telemetry during her stay; however, was asymptomatic. These were monitored on TELE. She also had one instance of bradycardia during stay while sleeping, which was also asymptomatic. EKG was obtained which did not show any acute changes. Patient completed O2 walk prior to discharge and required 0L at rest and 1L with exertion. She was discharged in stable condition with detailed discharge instructions. Patient completed treatment for COVID-19 inpatient. Dishcarged on 1/19/22
Information has been received from a pharmacist concerning a 60 year old female with no known drug reactions or allergies who on 17-SEP-2008 was vaccinated with a dose of ZOSTAVAX (Merck).  On 18-SEP-2008 the patient's arm was red, sore, itchy, and hot at the injection site.  The patient sought medical attention at the office and was treated with ice.  At time of reporting, the patient had not recovered.  This is one of two reports from the same source.  Additional information has been requested.
1 week after vaccination with Moderna Covid vaccine, patient experienced itching at vaccination site, swelling and tenderness of arm and armpit area. Resolved without treatment.
memory lost; Initial information was received on 05-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer.  This case involves a patient of an unknown demographics who had memory lost last year (amnesia), after the patient received INFLUENZA VACCINE.  Medical history, past medical treatments, vaccinations, Concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date in the last year, the patient developed non-serious memory lost (amnesia) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  The outcome of the event was unknown.  There will be no information available on the batch number for this case.
3/8/2021 - I woke @ 5:00 am with body aches and chills.  Ran fever throughout the day ranging from 99.2 - 100.6.   3/9/2021 - I woke approx 6:00 am and above symptoms were gone and I felt fine.   3/10/2021 - My left are became painful as the day progressed and developed a raised, red rash approx 3" below injection sight, hot to the touch.  It felt as if I had been punched in the arm many times and it was difficult to sleep on left arm and also was painful to the touch. 3/14/2021 - rash is gone and now area just feels like it's slightly bruised.
Within about 8 hrs of receiving flu vaccine began to feel weak, achey and feverish; within 12 hrs he broke out with a small red pinpoint sized rash on his trunk; no anaphylactic symptoms experienced; saw physician twice, received medication for symptoms, was ill and missed work 6 days.
4-year-old rash.  Based on history and clinical exam low suspicion for cellulitis, impetigo, zoster. Differential includes contact dermatitis, viral exanthem. allergic reaction (though with no hives). Plan for PO cetirizine.  Close outpatient follow-up.  Discharged in stable condition.
Right side of face (from mid eyebrow-line to below temple) became numb and has a "pins-and-needles" sensation when touched.
Experience head ache, body ache, sore right arm on the area where the shot was given and was  red  5"  circumference  where shot was given.
Shortness of breath; Tightness in her chest; Body pain; Weakness; Pain in both legs; weakness in her legs; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), CHEST DISCOMFORT (Tightness in her chest), PAIN (Body pain), ASTHENIA (Weakness) and PAIN IN EXTREMITY (Pain in both legs) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 2007321A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced DYSPNOEA (Shortness of breath), CHEST DISCOMFORT (Tightness in her chest), PAIN (Body pain), ASTHENIA (Weakness), PAIN IN EXTREMITY (Pain in both legs), MUSCULAR WEAKNESS (weakness in her legs) and HEADACHE (Headache). At the time of the report, DYSPNOEA (Shortness of breath), CHEST DISCOMFORT (Tightness in her chest), PAIN (Body pain), ASTHENIA (Weakness), PAIN IN EXTREMITY (Pain in both legs), MUSCULAR WEAKNESS (weakness in her legs) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were mentioned. No treatment drugs were reported.
presented to healthcare alert with mild confusion and hypotensive.  Temp 100.4  IV fluids started and sent to ER for further evaluation.
About a week after vaccination, a rash erupted over the majority of the body.  It has never resolved- has been present for the last 7 years.  Only in 2016 was it finally diagnosed after biopsy as Pityriasis Rubra Pilaris .
Systemic: Dizziness / Lightheadness-Mild, Systemic: Visual Changes/Disturbances-Mild, Additional Details: within ~ 5 minutes of dose administration, patient's mother got our attention that the patient was having a reaction. Patient was pale and lightheaded/dizzy and complained of blurred vision severe enough that she could not see my hand in front of her face. Patient remained concious. Pt was instructed to place their head within their lap and remain in the chair and was given a cold water to sip. within ~ 10min the vision changes returned to normal, & the lightheadedness subsided after 15 min.